Antiviral Activity of Technologically Processed Antibodies to CD4 Receptor against Influenza Infection

被引：0
|
作者：
Petrova, N. V. [1 ,3 ]
Emelyanova, A. G. [1 ,3 ]
Tarasov, S. A. [1 ,3 ]
Glubokova, E. A. [2 ]
Kartashova, N. P. [2 ]
机构：
[1] Res Inst Gen Pathol & Pathophysiol, Moscow, Russia
[2] II Mechnikov Res Inst Vaccines & Sera, Moscow, Russia
[3] LLC MATERIA MEDICA HOLDING, Moscow, Russia
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2022年 / 174卷 / 02期
关键词：
influenza A infection; technologically processed antibodies; CD4; receptor; Ergoferon; Raphamin; EFFICACY; OSELTAMIVIR; ERGOFERON; SAFETY;
D O I：
10.1007/s10517-023-05683-8
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The antiviral activity of technologically processed antibodies to CD4 receptor was evaluated a model of sublethal A/California/04/2009 (H1N1)pdm09-induced influenza infection in female BALB/c mice. The technologically processed antibodies increased animal survival rate by 50% in comparison with the placebo group (p < 0.05), which correlated with significant inhibition of virus replication in the lungs (p < 0.05). The reference drug Tamiflu increased mouse survival rate (by 47%), decreased the virus titer in the lungs, and prevented body weight loss (p < 0.05 in comparison with the placebo group by all parameters). The intrinsic protective activity of technologically processed antibodies to CD4 receptor was demonstrated, which manifested in a decrease in viral load in the lower respiratory tract and an increase in the survival rate.
引用
收藏
页码：250 / 253
页数：4
相关论文
共 50 条
  • [1] Antiviral Activity of Technologically Processed Antibodies to CD4 Receptor against Influenza Infection
    N. V. Petrova
    A. G. Emelyanova
    S. A. Tarasov
    Е. А. Glubokova
    N. P. Каrtashova
    Bulletin of Experimental Biology and Medicine, 2022, 174 : 250 - 253
  • [2] CD4 receptor diversity in chimpanzees protects against SIV infection
    Bibollet-Ruche, Frederic
    Russell, Ronnie M.
    Liu, Weimin
    Stewart-Jones, Guillaume B. E.
    Sherrill-Mix, Scott
    Li, Yingying
    Learn, Gerald H.
    Smith, Andrew G.
    Gondim, Marcos V. P.
    Plenderleith, Lindsey J.
    Decker, Julie M.
    Easlick, Juliet L.
    Wetzel, Katherine S.
    Collman, Ronald G.
    Dingh, Shilei
    Finzih, Andres
    Ayouba, Ahidjo
    Peeters, Martine
    Leendertz, Fabian H.
    van Schijndel, Joost
    Goedmakers, Annemarie
    Ton, Els
    Boesch, Christophe
    Kuehl, Hjalmar
    Arandjelovic, Mimi
    Dieguez, Paula
    Murai, Mizuki
    Colin, Christelle
    Koops, Kathelijne
    Speede, Sheri
    Gonder, Mary K.
    Muller, Martin N.
    Sanz, Crickette M.
    Morgan, David B.
    Atencia, Rebecca
    Cox, Debby
    Piel, Alex K.
    Stewart, Fiona A.
    Ndjango, Jean-Bosco N.
    Mjungu, Deus
    Lonsdorf, Elizabeth V.
    Pusey, Anne E.
    Kwong, Peter D.
    Sharp, Paul M.
    Shaw, George M.
    Hahn, Beatrice H.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (08) : 3229 - 3238
  • [3] The extracellular domain of CD4 receptor possesses a protein kinase activity
    Yakubov, LA
    Kit, YY
    Richter, VA
    Andreeva, AY
    Karamyshev, VN
    Stein, CA
    Vlassov, VV
    FEBS LETTERS, 1998, 431 (01) : 45 - 48
  • [4] Inhibitors of HIV infection via the cellular CD4 receptor
    Vermeire, K
    Schols, D
    Bell, TW
    CURRENT MEDICINAL CHEMISTRY, 2006, 13 (07) : 731 - 743
  • [5] The Differentiation and Protective Function of Cytolytic CD4 T Cells in influenza infection
    Brown, Deborah M.
    Lampe, Anna T.
    Workman, Aspen M.
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [6] The antiviral effects of baloxavir marboxil against influenza A virus infection in ferrets
    Kitano, Mitsutaka
    Matsuzaki, Takanobu
    Oka, Ryoko
    Baba, Kaoru
    Noda, Takahiro
    Yoshida, Yuki
    Sato, Kenji
    Kiyota, Kohei
    Mizutare, Tohru
    Yoshida, Ryu
    Sato, Akihiko
    Kamimori, Hiroshi
    Shishido, Takao
    Naito, Akira
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2020, 14 (06) : 710 - 719
  • [7] Insights into the interaction of CD4 with anti-CD4 antibodies
    Van-Chien Bui
    Thi-Huong Nguyen
    IMMUNOBIOLOGY, 2017, 222 (02) : 148 - 154
  • [8] CD4 responses against IDO
    Andersen, Mads Hald
    ONCOIMMUNOLOGY, 2012, 1 (07): : 1211 - 1212
  • [9] Fusion proteins of HIV-1 envelope glycoprotein gp120 with CD4-induced antibodies showed enhanced binding to CD4 and CD4 binding site antibodies
    Chen, Weizao
    Feng, Yang
    Wang, Yanping
    Zhu, Zhongyu
    Dimitrov, Dimiter S.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 425 (04) : 931 - 937
  • [10] CRYPTOSPORIDIUM INFECTION AND CD4 COUNTS
    FLANIGAN, T
    WHALEN, C
    TURNER, J
    SOAVE, R
    TOERNER, J
    HAVLIR, D
    KOTLER, D
    ANNALS OF INTERNAL MEDICINE, 1992, 116 (10) : 840 - 842
12345